Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 551–600 of 1,396 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05683171	A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma	active not recruiting	Phase 1 / Phase 2	16	M.D. Anderson Cancer CenterOTHER	1	Jun 29, 2026	clinicaltrials
NCT02520791	Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma	active not recruiting	Phase 1	21	National Cancer Institute (NCI)NIH	2